| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. | Clin Exp Metastasis | 2009 | 1.94 |
| 2 | Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator. | Cancer Biol Ther | 2006 | 1.53 |
| 3 | BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. | Int J Cancer | 2011 | 1.08 |
| 4 | Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. | Stem Cells | 2010 | 1.03 |
| 5 | Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. | Clin Cancer Res | 2008 | 1.02 |
| 6 | Integrated molecular profiling of SOD2 expression in multiple myeloma. | Blood | 2006 | 0.97 |
| 7 | DNA hypermethylation and partial gene silencing of human thymine- DNA glycosylase in multiple myeloma cell lines. | Epigenetics | 2006 | 0.90 |